– USA, IN – Zimmer Biomet Holdings, Inc. (NYSE: ZBH / SIX: ZBH), a global medical technology leader, today announced the appointment of Lou Shapiro to its Board of Directors, effective immediately.
“With a long history of leadership in the industry, and as the former President and CEO of a leading healthcare system, Lou brings a significant depth of industry leadership experience, a unique customer perspective and a shared lifetime commitment to our mission to alleviate pain and improve the quality of life for people around the world,” said Board Chairman, Chris Begley.
About Louis A. Shapiro
Lou Shapiro joined HSS as its President and CEO in October 2006, retiring in October 2023. Before joining HSS, Mr. Shapiro worked at Geisinger Health System from 2002-2006, serving in roles with increasing leadership scope and ultimately advancing to EVP and COO of the Clinical Enterprise. He served as a senior healthcare expert and consultant at McKinsey & Co. from 1999-2002 and held positions in other hospitals and health systems from 1983 through 1999. Mr. Shapiro also previously served as a founding member of the board of directors of RightMove Health, as President of Medical Indemnify Assurance Company, and as the Board Chair of the Greater New York Hospital Association, in addition to holding several other board and advisory roles throughout his career.
Mr. Shapiro has a bachelor of science degree in psychology from the University of Pittsburgh and a master’s degree in health administration from the University of Pittsburgh Graduate School of Public Health.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics, and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
SOURCE: www.zimmerbiomet.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.